Olicon to focus efforts on its OEM customersPACS firm Olicon Imaging Systems has decided to shift most sales efforts to OEM distribution opportunities with healthcare information systems firms, particularly with partner Shared Medical Systems.
PACS firm Olicon Imaging Systems has decided to shift most sales efforts to OEM distribution opportunities with healthcare information systems firms, particularly with partner Shared Medical Systems. As part of this transition, 30% of the Aliso Viejo, CA-based company's sales staff was eliminated.
"Ultimately the players who will win in the PACS business will be those who have not interfaced but have integrated PACS and RIS," said Dick Paulsen, CEO. "We have done that with SMS."
Integration work between Olicon and SMS will be displayed by both companies at this year's Radiological Society of North America meeting, Paulsen said. In addition to the relationship with SMS, Olicon is working to add more HIS relationships, he said.
Some direct sales will still be performed, however, with emphasis on large radiology groups and imaging center networks, Paulsen said.
Rumors have also been swirling about a sale of the company's teleradiology archiving program (TAP), which allows customers to handle their long-term storage needs in off-site archives at an Olicon warehouse. When needed, the image is sent via teleradiology to the customer's workstation. The availability of TAP has been broadened to support DICOM-compatible workstations from other PACS vendors, a milestone that has sparked growing interest in the division, either for acquisition by another company or for marketing relationships, Paulsen said.
An offer to purchase the TAP division was made, and Paulsen brought it to the company's board of directors. The company has received many such offers, however, Paulsen said.
Study: AI Boosts Ultrasound AUC for Predicting Thyroid Malignancy Risk by 34 Percent Over TI-RADS
February 17th 2025In a study involving assessment of over 1,000 thyroid nodules, researchers found the machine learning model led to substantial increases in sensitivity and specificity for estimating the risk of thyroid malignancy over traditional TI-RADS and guidelines from the American Thyroid Association.
Can CT-Based AI Provide Automated Detection of Colorectal Cancer?
February 14th 2025For the assessment of contrast-enhanced abdominopelvic CT exams, an artificial intelligence model demonstrated equivalent or better sensitivity than radiologist readers, and greater than 90 percent specificity for the diagnosis of colorectal cancer.
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.